These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26956510)

  • 1. Elevated systemic galectin-1 levels characterize HELLP syndrome.
    Schnabel A; Blois SM; Meint P; Freitag N; Ernst W; Barrientos G; Conrad ML; Rose M; Seelbach-Göbel B
    J Reprod Immunol; 2016 Apr; 114():38-43. PubMed ID: 26956510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-1 as a novel risk factor for both gestational hypertension and preeclampsia, specifially its expression at a low level in the second trimester and a high level after onset.
    Hirashima C; Ohkuchi A; Nagayama S; Suzuki H; Takahashi K; Ogoyama M; Takahashi H; Shirasuna K; Matsubara S
    Hypertens Res; 2018 Jan; 41(1):45-52. PubMed ID: 28978981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of preeclampsia with soluble Fms-like tyrosine kinase 1/placental growth factor ratio: an inter-assay comparison.
    Andersen LB; Frederiksen-Møller B; Work Havelund K; Dechend R; Jørgensen JS; Jensen BL; Nielsen J; Lykkedegn S; Barington T; Christesen HT
    J Am Soc Hypertens; 2015 Feb; 9(2):86-96. PubMed ID: 25600419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
    J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas.
    Jeschke U; Mayr D; Schiessl B; Mylonas I; Schulze S; Kuhn C; Friese K; Walzel H
    Placenta; 2007; 28(11-12):1165-73. PubMed ID: 17664004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
    Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
    J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies.
    Leaños-Miranda A; Campos-Galicia I; Berumen-Lechuga MG; Molina-Pérez CJ; García-Paleta Y; Isordia-Salas I; Ramírez-Valenzuela KL
    J Rheumatol; 2015 Jul; 42(7):1141-9. PubMed ID: 25979720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia.
    Krauss T; Pauer HU; Augustin HG
    Hypertens Pregnancy; 2004; 23(1):101-11. PubMed ID: 15117604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.
    Wikström AK; Larsson A; Eriksson UJ; Nash P; Nordén-Lindeberg S; Olovsson M
    Obstet Gynecol; 2007 Jun; 109(6):1368-74. PubMed ID: 17540809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-1 influences trophoblast immune evasion and emerges as a predictive factor for the outcome of pregnancy.
    Tirado-González I; Freitag N; Barrientos G; Shaikly V; Nagaeva O; Strand M; Kjellberg L; Klapp BF; Mincheva-Nilsson L; Cohen M; Blois SM
    Mol Hum Reprod; 2013 Jan; 19(1):43-53. PubMed ID: 23002109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
    Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic factors and acute-phase proteins in serum samples of preeclampsia and HELLP patients: a matched-pair analysis.
    Reimer T; Rohrmann H; Stubert J; Pecks U; Glocker MO; Richter DU; Gerber B
    J Matern Fetal Neonatal Med; 2013 Feb; 26(3):263-9. PubMed ID: 23020582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear transcription factor-kappa beta-dependent ultrastructural alterations within the placenta and systemic inflammatory activation in pregnant patients with hemolysis, elevated liver functions and low thrombocyte count (HELLP) syndrome: a case-control study.
    Simsek Y; Gul M; Celik O; Aydin NE; Arda Düz S; Celik E; Ozerol E; Özerol IH; Tanbek K
    Hypertens Pregnancy; 2013 Aug; 32(3):281-91. PubMed ID: 23905607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of maternal serum angiogenic factors in third-trimester normal pregnancies: reference ranges, influence of maternal and pregnancy factors and fetoplacental Doppler indices.
    Lobmaier SM; Figueras F; Mercade I; Crovetto F; Peguero A; Parra-Saavedra M; Ortiz JU; Crispi F; Gratacós E
    Fetal Diagn Ther; 2014; 36(1):38-43. PubMed ID: 24903330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK; Chandel N; Jain V; Jha V
    J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset threshold of the plasma levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation.
    Ohkuchi A; Hirashima C; Takahashi K; Suzuki H; Matsubara S; Suzuki M
    Hypertens Res; 2013 Dec; 36(12):1073-80. PubMed ID: 23966056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of thrombospondin-1 are decreased in HELLP syndrome.
    Stenczer B; Molvarec A; Szabó G; Szarka A; Fügedi G; Szijártó J; Rigó J
    Thromb Res; 2012 Apr; 129(4):470-3. PubMed ID: 22035632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PP052. The course of sFlt-1 and PLGF reflects different progression pattern in early- versus late-onset preeclampsia and HELLP syndrome.
    Schaarschmidt W; Rana S; Stepan H
    Pregnancy Hypertens; 2012 Jul; 2(3):269. PubMed ID: 26105375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
    Moore Simas TA; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Maynard SE
    J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1038-48. PubMed ID: 24066977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia.
    Wortelboer EJ; Koster MP; Cuckle HS; Stoutenbeek PH; Schielen PC; Visser GH
    BJOG; 2010 Oct; 117(11):1384-9. PubMed ID: 20840693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.